Logo image
Puromycin- and methotrexate-resistance cassettes and optimized Cre-recombinase expression plasmids for use in yeast
Journal article   Open access   Peer reviewed

Puromycin- and methotrexate-resistance cassettes and optimized Cre-recombinase expression plasmids for use in yeast

Chris MacDonald and Robert C. Piper
Yeast (Chichester, England), Vol.32(5), pp.423-438
05/01/2015
DOI: 10.1002/yea.3069
PMCID: PMC4454448
PMID: 25688547
url
https://www.ncbi.nlm.nih.gov/pmc/articles/4454448View
Open Access

Abstract

Here we expand the set of tools for genetically manipulating Saccharomyces cerevisiae. We show that puromycin-resistance can be achieved in yeast through expression of a bacterial puromycin-resistance gene optimized to the yeast codon bias, which in turn serves as an easy-to-use dominant genetic marker suitable for gene disruption. We have constructed a similar DNA cassette expressing yeast codon-optimized mutant human dihydrofolate reductase (DHFR), which confers resistance to methotrexate and can also be used as a dominant selectable marker. Both of these drug-resistant marker cassettes are flanked by loxP sites, allowing for their excision from the genome following expression of Cre-recombinase. Finally, we have created a series of plasmids for low-level constitutive expression of Cre-recombinase in yeast that allows for efficient excision of loxP-flanked markers. Copyright (c) 2015 John Wiley & Sons, Ltd.
Biochemistry & Molecular Biology Biotechnology & Applied Microbiology Life Sciences & Biomedicine Microbiology Mycology Science & Technology

Details

Logo image